The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Regorafenib in metastatic colorectal cancer: An exploratory biomarker trial.
 
Mohamed E. Salem
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst)
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera; Theranostics Health
Stock and Other Ownership Interests - Ceres Nanosciences; Perthera; Theranostics Health
Honoraria - Ceres Nanosciences; Novartis; Perthera; Symphony Evolution; Theranostics Health
Consulting or Advisory Role - Ceres Nanosciences; Novartis; Perthera; Theranostics Health
Research Funding - Ceres Nanosciences (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera
 
Anton Wellstein
No Relationships to Disclose
 
Mariaelena Pierobon
No Relationships to Disclose
 
Hongkun Wang
No Relationships to Disclose
 
Sameh Mikhail
No Relationships to Disclose
 
Marion L. Hartley
No Relationships to Disclose
 
Brandon George Smaglo
No Relationships to Disclose
 
Emil Lou
No Relationships to Disclose
 
Angela Tatiana Alistar
No Relationships to Disclose
 
Karen Dorsch-Vogel
No Relationships to Disclose
 
Michael J. Pishvaian
No Relationships to Disclose
 
Aiwu Ruth He
No Relationships to Disclose
 
Alexander Y. Kim
No Relationships to Disclose
 
Narayan Shivapurkar
No Relationships to Disclose
 
Sandeep K. Reddy
No Relationships to Disclose
 
John Marshall
Honoraria - Amgen; Bayer/Onyx; Boehringer Ingelheim; Daiichi Sankyo; Genentech/Roche
Consulting or Advisory Role - Amgen; Bayer/Onyx; Boehringer Ingelheim; Daiichi Sankyo; Genentech/Roche
Speakers' Bureau - Amgen; Bayer/Onyx; Genentech/Roche
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst)